David R. Ebsworth, Director at Verona Pharma plc (VRNA), sold 11,912 shares at $0.99 ($12K) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Scheduled sale ($12k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRNA | BUY | 2024-11-07 | $189K | — | Filing → |
| VRNA | BUY | 2024-08-14 | $103K | — | Filing → |
| VRNA | BUY | 2023-11-08 | $317K | — | Filing → |